Gemcitabine HCl

Open studies are marked with a purple background, closed studies have a grey background, studies to be opened have a white background
08013
Phase II study with Gefitinib (sequentially) following Gemcitabine/Cisplatin as induction regimen for patients with stage IIIA N2 NSCLC
24982
Phase II study on Gemcitabine in Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck
20021
Gem-(R)CHOP versus (R)CHOP : a randomized Phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's Lymphoma
40013
Randomised phase II/III study comparing gemcitabine followed by gemcitabine plus concomitant radiation (50.4 Gy) versus gemcitabine alone after curative pancreaticoduodenectomy for pancreatic head cancer
08012
Pre-operative chemotherapy in resectable NSCLC. Randomised trial of surgical resection with or without pre-operative chemotherapy in patients with operable non small cell lung cancer (NSCLC) of any stage.
30994
 Randomized phase III trial comparing immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4, and/or N+M0 transitional cell carcinoma (TCC) of the bladder
30987
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and cisplatin/gemcitabine in patients with metastatic or locally advanced urothelial cancer without prior systemic therapy.
30986
Randomized phase II/III study assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in previously untreated patients with advanced urothelial cancer ineligible for Cisplatin based chemotherapy.

Back to Protocol section